Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Código da empresaCDXS
Nome da EmpresaCodexis Inc
Data de listagemApr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.
Número de funcionários188
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 22
Endereço200 Penobscot Dr
CidadeREDWOOD CITY
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94063
Telefone16504218100
Sitehttps://www.codexis.com/
Código da empresaCDXS
Data de listagemApr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados